OR WAIT null SECS
Novotech has announced the acquisition of CBR International, a global product development, clinical oversight, and strategic regulatory operations group.
CBR was founded in 2002 as a consultancy company focused on assisting biotechnology and pharma companies navigate FDA requirements from early-stage development through to approval. CBR adds a group of experts to Novotech to provide US and global regulatory, scientific, quality, and clinical development services.
Read more about the acquisition here.